184 related articles for article (PubMed ID: 36026496)
1. Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus.
Chang YK; Fan HC; Lin CC; Wang YH; Tsai WN; Lim PS
PLoS One; 2022; 17(8):e0273646. PubMed ID: 36026496
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan.
Shen CH; Zheng CM; Kiu KT; Chen HA; Wu CC; Lu KC; Hsu YH; Lin YF; Wang YH
Medicine (Baltimore); 2016 Jun; 95(25):e3933. PubMed ID: 27336884
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.
Liao JN; Chao TF; Liu CJ; Wang KL; Chen SJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Chen SA
Kidney Int; 2015 Jun; 87(6):1209-15. PubMed ID: 25587708
[TBL] [Abstract][Full Text] [Related]
4. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.
Bansal N; Fan D; Hsu CY; Ordonez JD; Marcus GM; Go AS
Circulation; 2013 Feb; 127(5):569-74. PubMed ID: 23275377
[TBL] [Abstract][Full Text] [Related]
5. Comparison of incidence of acute kidney injury, chronic kidney disease and end-stage renal disease between atrial fibrillation and atrial flutter: real-world evidences from a propensity score-matched national cohort analysis.
Hu WS; Lin CL
Intern Emerg Med; 2019 Oct; 14(7):1113-1118. PubMed ID: 31073825
[TBL] [Abstract][Full Text] [Related]
6. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
Chao CT; Lee SY; Wang J; Chien KL; Hung KY
Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
[TBL] [Abstract][Full Text] [Related]
7. Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure.
Hwang JC; Jiang MY; Lu YH; Weng SF
Medicine (Baltimore); 2016 Jan; 95(3):e2431. PubMed ID: 26817874
[TBL] [Abstract][Full Text] [Related]
8. The CHA
Wang CJ; Hsieh YP; Kor CT; Chiu PF
Int Urol Nephrol; 2020 Aug; 52(8):1523-1531. PubMed ID: 32488758
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
[TBL] [Abstract][Full Text] [Related]
10. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease.
Chang CH; Lee YC; Tsai CT; Chang SN; Chung YH; Lin MS; Lin JW; Lai MS
Atherosclerosis; 2014 Jan; 232(1):224-30. PubMed ID: 24401243
[TBL] [Abstract][Full Text] [Related]
11. End Stage Renal Disease as a Potential Risk Factor for Retinal Vein Occlusion.
Chen SN; Yang TC; Lin JT; Lian IB
Medicine (Baltimore); 2015 Nov; 94(47):e1960. PubMed ID: 26632690
[TBL] [Abstract][Full Text] [Related]
12. Risk of Retinal Vein Occlusion Following End-Stage Renal Disease.
Chang YS; Weng SF; Chang C; Wang JJ; Tseng SH; Wang JY; Jan RL
Medicine (Baltimore); 2016 Apr; 95(16):e3474. PubMed ID: 27100450
[TBL] [Abstract][Full Text] [Related]
13. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
[TBL] [Abstract][Full Text] [Related]
14. Chronic Kidney Disease Progression Risk in Patients With Diabetes Mellitus Using Dihydropyridine Calcium Channel Blockers: A Nationwide, Population-Based, Propensity Score Matching Cohort Study.
Lin SY; Lin CL; Lin CC; Hsu WH; Hsu CY; Kao CH
Front Pharmacol; 2022; 13():786203. PubMed ID: 35355728
[No Abstract] [Full Text] [Related]
15. Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study.
Kwon S; Lee SR; Choi EK; Jung JH; Han KD; Oh S; Lip GYH
Clin Res Cardiol; 2022 Mar; 111(3):284-293. PubMed ID: 34216251
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes.
Heo NJ; Rhee SY; Waalen J; Steinhubl S
Cardiovasc Diabetol; 2020 Sep; 19(1):157. PubMed ID: 32998739
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
[TBL] [Abstract][Full Text] [Related]
18. Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease.
Chen TH; Chu YC; Ou SM; Tarng DC
Heart; 2022 Mar; 108(6):438-444. PubMed ID: 34193464
[TBL] [Abstract][Full Text] [Related]
19. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy Following End-Stage Renal Disease.
Chang YS; Weng SF; Chang C; Wang JJ; Su SB; Huang CC; Wang JY; Jan RL
Medicine (Baltimore); 2016 Mar; 95(12):e3174. PubMed ID: 27015205
[TBL] [Abstract][Full Text] [Related]
20. Separate and joint effects of diabetes mellitus and chronic kidney disease on the risk of acute coronary syndrome: a population-based cohort study.
Chang YT; Liu CC; Tsai LM; Li CY; Sung JM
Medicine (Baltimore); 2014 Dec; 93(28):e261. PubMed ID: 25526451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
